ACIP unanimously recommends Dengvaxia use, with same caveats as FDA label; Chinese 3D printing company with rheumatoid arthritis drug completes Series B financing
ACIP has recommended use of Sanofi’s dengue vaccine by a unanimous vote, but there’s a catch.
With the 14-0 vote Thursday, ACIP said the shots …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
